Pfizer (PFE) Gross Margin (2009 - 2026)
Pfizer (PFE) posted quarterly Gross Margin of 75.45% for Q1 2026, down 381.0% year-over-year from 26.85% in Q1 2025, and down 34.25% quarter-over-quarter from 114.74% in Q4 2025.
Pfizer (PFE) Gross Margin (2009 - 2026) Analysis & Trends
Pfizer (PFE) has reported Gross Margin for 18 consecutive years, with 75.45% the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Margin fell 381.0% year-over-year to 75.45%; the TTM figure through Mar 2026 stood at 805.21% (up 73044.0% YoY), while the FY2025 annual figure was 73.4%, up 3942.0% from the prior year.
- Gross Margin fell to 75.45% in Q1 2026 per PFE's latest filing, from 114.74% in the prior quarter.
- Across five years, Gross Margin topped out at 114.74% in Q4 2025 and bottomed at 120.24% in Q4 2023.
- Historically, Gross Margin has averaged 36.97% across 5 years, with a median of 68.97% in 2024.
- Annual changes were most pronounced in 2024 — Gross Margin jumped 11200 bps — and 2025, when it plunged 13519 bps.
- Pfizer's Gross Margin stood at 68.83% in 2022, then slumped by 275 bps to 120.24% in 2023, then soared by 162 bps to 73.96% in 2024, then jumped by 55 bps to 114.74% in 2025, then sank by 34 bps to 75.45% in 2026.
- Business Quant data shows PFE's Gross Margin at 75.45% in Q1 2026, 114.74% in Q4 2025, and 74.95% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 72.78% |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 73.05% |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 80.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 72.78% |
| Mar 29, 2026 | 75.45% |
| Dec 31, 2025 | 114.74% |
| Sep 28, 2025 | 74.95% |
| Jun 29, 2025 | -66.21% |
| Mar 30, 2025 | 79.26% |
| Sep 29, 2024 | 73.96% |
| Jun 30, 2024 | 68.97% |
| Mar 31, 2024 | 77.29% |
| Dec 31, 2023 | -120.24% |
| Jul 2, 2023 | 7.25% |
| Apr 2, 2023 | -34.71% |
| Jul 3, 2022 | 68.83% |
| Apr 3, 2022 | 61.09% |
| Oct 3, 2021 | 63.30% |
| Jul 4, 2021 | 62.98% |
| Apr 4, 2021 | 71.36% |
| Sep 27, 2020 | 80.90% |
| Jun 28, 2020 | 81.49% |
| Mar 29, 2020 | 80.76% |